Intractable epilepsy secondary to cyclosporine toxicity in children undergoing allogeneic hematopoietic bone marrow transplantation

Journal of Child Neurology

Volumn 21, Issue 10, 2006, Pages 861-866

  Gaggero, Roberto ^a   Haupt, Riccardo ^a   Fondelli, Maria Paola ^b   De Vescovi, Raffaella ^c   Marino, Alessia ^a   Lanino, Edoardo ^a   Dallorso, Sandro ^a   Faraci, Maura ^a  

^a G GASLINI INSTITUTE   (Italy)

^b GALLIERA HOSPITAL   (Italy)

^c INSTITUTE FOR MATERNAL AND CHILD HEALTH IRCCS BURLO GAROFOLO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE; CYCLOSPORIN; HYDANTOIN; IMMUNOSUPPRESSIVE AGENT; THIOPENTAL;

ADOLESCENT; AGE; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; DISEASE ASSOCIATION; DRUG BLOOD LEVEL; DRUG DOSE REDUCTION; DRUG MEGADOSE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ELECTROENCEPHALOGRAM; EPILEPTIC STATE; FEMALE; FOCAL EPILEPSY; GRAFT VERSUS HOST REACTION; GRAND MAL SEIZURE; HIPPOCAMPAL SCLEROSIS; HUMAN; INTRACTABLE EPILEPSY; MALE; MORTALITY; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCIPITAL LOBE; PRIORITY JOURNAL; RELAPSE; REMISSION; RISK FACTOR; TEMPORAL LOBE EPILEPSY; TREATMENT DURATION;

ADOLESCENT; BONE MARROW TRANSPLANTATION; BRAIN DISEASES; CHILD; CHILD, PRESCHOOL; CYCLOSPORINE; ELECTROENCEPHALOGRAPHY; EPILEPSY; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MAGNETIC RESONANCE IMAGING; MALE; RISK FACTORS; TEMPORAL LOBE; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 33846263018     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.1177/08830738060210100501     Document Type: Article

References (27)

1. Reece DE, Frei-Lahar DA, Shephers JD, et al: Neurologic complication in allogenic bone marrow transplant patients receiving cyclosporine. BMT 1991;8:393-401.
2. Gijtenbeek JM, van den Bent MJ, Vecht CJ, et al: Cyclosporine neurotoxicity: A review. J Neurol 1999;246:339-346.
3. Gleeson JG, DuPleiss AJ, Barnes PD, Riviello JJ Jr. Cyclosporine-A acute encephalopathy and seizure syndrome in childhood: Clinical features and risk of seizure recurrence. J Child Neurol 1998;13:3336-3344.
4. Antonini G, Ceschin V, Morino S, et al: Early neurologic complications following allogeneic bone marrow transplant for leukemia: A prospective study. Neurology 1998;50:1441-1445.
5. Pratt G, Kennedy B, Smith G: Cyclosporine neurotoxicity after chemotherapy. BMJ 1999;319:54-55.
6. Faraci M, Lanino E, Dini G, et al: Severe neurological complication after stem cell transplantation in children. Neurology 2002; 59:18951904.
7. Faraci M, Lanino E, Dallorso S, et al: Mesial temporal sclerosis - A late complication in four allogenic pediatric recipients with persistent seizures after an acute episode of cyclosporine-A neurotoxicity. BMT 2003;31:919-922.
8. Engel J Jr. A proposed diagnostic scheme for people with epileptic seizures and with epilepsy: Report of the ILAE Task Force on Classification and Terminology. Epilepsia 2001;42:796-803.
9. Blume WT, Luders O, Mizrahi E, et al: ILAE Commission Report: Glossary of descriptive terminology for ictal semiology: Report of the ILAE Task Force on Classification and Terminology. Epilepsia 2001-142:1212-1218.
10. Hincey J, Chaves C, Appiani B, et al: A reversible posterior leukoencephalopathy syndrome. N Engl J Med 1996;334:494-500.
11. Truwit CL, Denaro CP, Lake JR, De Marco T: MR imaging of reversible cyclosporine A-induced neurotoxicity. AJNR Am J Neuroradiol 1991;12:651-659.
12. Teive HA, Brandi IV, Camargo CH, et al: Reversible posterior leukoencephalopathy syndrome associated with bone marrow transplantation. Arq Neuropsiquiatr 2001;59:784-789.
13. Bechstein W: Neurotoxicity of calcineurin inhibitors: Impact and clinical management. Transpl Int 2000;13:313-326.
14. Chang SH, Lim CS, Low TS, et al: Cyclosporine associated encephalopathy: A case report and literature review. Transplant Proc 2001;33:3700-3701.
15. Shbarou RM, Chao NJ, Morgenlander JC: Cyclosporine-A related cerebral vasculopathy. BMT 2000;26:801-804.
16. Woong M, Yamada KA: Cyclosporine induces epileptiform activity in a vitro model. Epilepsia 2000;41:271-276.
17. Tauboll E, Gerdis R, Gierstad L: Cyclosporine A and brain excitability studied in vitro. Epilepsia 1998;39:687-691.
18. Lowenstein DH, Thomas MS, Smith DH, et al: Selective vulnerability of dentate hilar neurons following traumatic brain injury: A potential mechanistic link between head trauma and disorders of the hippocampus. J Neurosci 1992;12:4846-4853.
19. Mather GW, Pretorius JK, Babba TL: Influence of the type of initial injury and what age it occurs on course and outcome in patients with temporal lobe seizures. J Neurosurg 1995;82:220-227.
20. Murakami N, Ohno S, Oka E, Tanaka A: Mesial temporal lobe epilepsy in childhood. Epilepsia 1996;37(Suppl 3):S52-S56.
21. Sanchez-Alvarez JC, Pastor-Pons E, Garcia-Gomez T, et al: Diagnosis of mesial temporal sclerosis with magnetic resonance imaging. Rev Neurol 2000;31:739-741.
22. Hogan RE: Mesial temporal sclerosis. Arch Neurol 2001;58:1484-1486.
23. Bruton CJ: The Neuropathology of Temporal Lobe Epilepsy. New York, Oxford University Press, 1994.
24. Mathern GW, Babb TL, Leite JP, et al: The pathologic and progressive features of chronic human hippocampal epilepsy. Epilepsy Res 1996;26:151-161.
25. Henter JL, Nennesmo I: Neuropathologic findings and neurologic symptoms in twenty-three children with hemophagocytic lymphohistiocytosis. J Pediatr 1997;130:337-338.
26. Blume WT, Holloway GM, Wiebe S: Temporal epileptogenesis: localizing value of scalp and subdural interictal and ictal EEG data. Epilepsia 2001;42:508-514.
27. Bourgeois BFD: General concepts of medical intractability, in Luders H (ed): Epilepsy Surgery. New York, Raven Press, 1992, 77-81.